Don't Miss What Matters at ESMO 2026 — Get the Intelligence That Shapes Your Next Move

Thelansis helped us stay on top of key ESMO developments without having to monitor every session ourselves. The real-time updates made it much easier for our team to identify and act on the developments that mattered.

Global Medical Affairs LeadTop 20 Pharma Company

What stood out was the level of competitive context. We weren't just receiving conference updates — we were getting a clear view of what the data meant for the competitive landscape.

Oncology Strategy LeadGlobal Biopharma

Thelansis effectively extended our internal team during the congress. Their dedicated analyst coverage allowed us to broaden our monitoring without adding significant bandwidth internally.

Director, Competitive IntelligenceGlobal Pharma

The value wasn't simply in the volume of information. Thelansis helped us separate the signal from the noise and translate important conference developments into actionable insights.

Senior Director, Business InsightsLeading Biotech

The post-congress synthesis was particularly valuable. We received a concise view of the most important data, competitive developments and potential implications for our portfolio.

VP, Commercial StrategyGlobal Biopharma

Thelansis understood our priorities before the conference and tailored the coverage accordingly. That made the output significantly more relevant than a standard conference summary.

Medical Affairs DirectorOncology Pharma

Having a trusted team tracking developments throughout the congress gave us confidence that we weren't missing important updates. Thelansis was responsive, reliable and consistently delivered on time.

Head of Market IntelligenceGlobal Pharmaceutical Company

Thelansis felt less like an external research provider and more like an extension of our team. Their ability to combine conference intelligence with strategic context made the engagement particularly valuable.

Global Oncology LeadLeading Biopharma Company